Dr. Michael Hall is a gastrointestinal oncologist, Professor of Medicine at Fox Chase Cancer Center and Co-Leader of the Cancer Prevention and Control Programs. He is a trained health services researcher and clinical cancer geneticist. He completed a fellowship in Hematology/Oncology at the University of Chicago where he established a clinical and research focus in GI cancers and genetic risk and earned a master’s degree in health services research. His current research includes the study of patient attitudes and preferences toward hereditary risk assessment and testing, novel methods to communicate of high risk information within families, and collaborative research in gene discovery and large testing database analyses. He is the recipient of individual and collaborative research funding from the Greenwall Foundation, ASCO, the Prevent Cancer Foundation, ECOG-ACRIN, and the National Cancer Institute. Along with Dr. Sarah Bass from the Temple University School of Public Health, he received a 5-year Health Equity grant from the American Cancer Society to study communication of genetic information from tumor molecular profile in African American cancer patients, and continues this research in Hispanic patients in an 2023 NCI-funded grant. He was the 2019 President of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancers and serves as the current Treasuer, and is a member of the NCCN Guidelines Colorectal Cancer Genetics Review Committee. He has served on the GI ASCO and National Meeting Scientific Committees and several other ASCO educational committees and is an academic adivsor to FORCE, Facing our RIsk of Cancer Empowered.